FLAMMINI, Lisa
 Distribuzione geografica
Continente #
NA - Nord America 2.230
EU - Europa 2.125
AS - Asia 1.166
SA - Sud America 66
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 5.638
Nazione #
US - Stati Uniti d'America 2.186
CN - Cina 599
IT - Italia 425
FI - Finlandia 399
SG - Singapore 384
IE - Irlanda 381
SE - Svezia 350
DE - Germania 159
UA - Ucraina 110
NL - Olanda 107
TR - Turchia 83
BR - Brasile 60
IN - India 43
CA - Canada 40
FR - Francia 39
CI - Costa d'Avorio 38
GB - Regno Unito 36
RU - Federazione Russa 30
BE - Belgio 29
CZ - Repubblica Ceca 15
AT - Austria 9
BD - Bangladesh 9
RO - Romania 9
ID - Indonesia 7
PL - Polonia 7
CH - Svizzera 6
EU - Europa 5
KR - Corea 5
JP - Giappone 4
VN - Vietnam 4
ES - Italia 3
HK - Hong Kong 3
IR - Iran 3
PA - Panama 3
PK - Pakistan 3
BO - Bolivia 2
IQ - Iraq 2
LT - Lituania 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SC - Seychelles 2
TH - Thailandia 2
TW - Taiwan 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
CM - Camerun 1
DZ - Algeria 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MC - Monaco 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
UY - Uruguay 1
Totale 5.638
Città #
Chandler 398
Dublin 380
Singapore 249
Santa Clara 228
Ann Arbor 222
Parma 182
Dearborn 149
Jacksonville 144
Ashburn 128
Beijing 125
Boardman 101
Shanghai 80
Nanjing 77
Izmir 73
Princeton 60
New York 52
Wilmington 39
Abidjan 38
Bremen 35
Groningen 33
Helsinki 31
Milan 31
San Mateo 29
Brussels 28
Bangalore 27
Toronto 26
Des Moines 25
Kunming 25
Chicago 24
Hebei 22
Jinan 22
Moscow 21
Guangzhou 20
Los Angeles 20
Shenyang 20
Nanchang 19
Marseille 18
Changsha 17
Fremont 16
Hefei 16
Seattle 16
Munich 15
Norwalk 13
Redmond 13
Brno 12
Jiaxing 12
Houston 11
Tianjin 11
Bologna 9
Council Bluffs 9
Montegaldella 9
Ottawa 9
Grafing 8
London 8
Modena 8
Woodbridge 8
Dallas 7
Jakarta 7
Nuremberg 7
Redwood City 7
Reggio Emilia 7
Zhengzhou 7
Düsseldorf 6
Hangzhou 6
Pune 6
Kraków 5
Lanzhou 5
Taizhou 5
Vienna 5
West Jordan 5
Altidona 4
Ardea 4
Brescia 4
Carpi 4
Chengdu 4
Curitiba 4
Falkenstein 4
Falls Church 4
Frankfurt am Main 4
Haikou 4
Kocaeli 4
Palermo 4
Pesaro 4
Rome 4
Stockholm 4
Zurich 4
Baotou 3
Belo Horizonte 3
Finale Emilia 3
Fuzhou 3
Istanbul 3
Manchester 3
Mantova 3
Mestre 3
Ningbo 3
Phoenix 3
São Paulo 3
Timisoara 3
Tulsa 3
Amsterdam 2
Totale 3.611
Nome #
1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5 amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6 carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10Hpyrimido[1,2-a [1,8]naphthyridine-6-carboxamide derivative 212
Targeting the Eph/ephrin system as anti-inflammatory strategy in IBD 172
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 162
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 141
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 137
3D-printed chitosan-based scaffolds: An in vitro study of human skin cell growth and an in-vivo wound healing evaluation in experimental diabetes in rats 135
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 129
Novel Analgesic Agents Obtained by Molecular Hybridization of Orthosteric and Allosteric Ligands 123
Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation 122
Amino acid derivatives as palmitoylethanolamide prodrugs: Synthesis, in vitro metabolism and in vivo plasma profile in rats 117
Polyphenol rich botanicals used as food supplements interfere with EphA2-ephrinA1 system. 114
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 114
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 108
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 105
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 100
Antitumoral effect of a nanotechnology-based photodynamic therapy. 97
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis 96
Hake fish bone as a calcium source for efficient bone mineralization 95
Rifaximin anti-inflammatory activity on bovine endometrium primary cell cultures: a preliminary study 95
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models 93
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 93
Botanicals used as food supplements interfering with EphA2-ephrinA1 system: a screening study 92
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 92
Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity 91
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 91
Analgesic activity of new hybrid muscarinic agonists in mice 90
UniPR1331: small Eph/ephrin antagonist beneficial in intestinal inflammation by interfering with type-B signaling 90
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 88
Role of 5-HT in intestinal ischemia-reperfusion: suppression of inflammatory events by 5-HT1A blockade in mice 88
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 86
Disruption of Eph-ephrin B signaling pathways mitigates inflammation in a murine model of Crohn’s disease 85
Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation. 85
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 83
Preliminary study of calcium balance and bone mineralization improvement by a new calcium supplement in growing rats 83
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 82
Preventive effect of 5-HT1A receptor agonist Buspirone on mesenteric ischemia/reperfusion-induced inflammatory injuries in mice 81
Development and validation of a LC-MS method with electrospray ionization for the determination of the imidazole H(3) antagonist ROS203 in rat plasma. 80
Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: preliminary pharmacological investigation. 79
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 77
Distinct Roles of α4β2 and α7 Nicotinic Receptors in the Modulation of Inflammatory Responses in TNBS-Induced Colitis 75
Lithocholic acid competitively inhibits EphA2-ephrinA1 binding: pharmacological and structural considerations. 74
Brain Pharmacokinetics of Non-Imidazole Biphenyl H3 Receptor Antagonists: a Liquid Chromatography/Electrospray-Mass Spectrometry and ex vivo Binding Study in Rats 74
Development and validation of a DESI-HRMS/MS method for the fast profiling of esomeprazole and its metabolites in rat plasma: a pharmacokinetic study. 74
Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation. 73
Multi-target-directed ligands: new histamine H3 receptor antagonists with anticholinesterase activity 73
Intestinal Hypoxia and reperfusion: role for Eph-ephrin system 73
Lithocholic acid competitively inhibitis EphA2-ephrinA1 binding: pharmacological and structural considerations. 72
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 72
Liquid chromatography-mass spectrometric method for determination of the non-imidazole H(3) -receptor antagonist UPR1056 in rat plasma. 70
Aminopyridine derivatives with anticholinesterase and antiamnesic activity 68
α7 Nicotinic Agonist AR-R17779 Protects Mice against 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis in a Spleen-Dependent Way 66
EphA2-ephrinA1 system in acute mesenteric inflammation due to ischemia-reperfusion in mice 64
In vitro pharmacology at human histamine H(3) receptors and brain access of non-imidazole alkylpiperidine derivatives. 63
Analgesic effects mediated by muscarinic ligands acting at both orthosteric and allosteric receptor binding sites 62
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines 62
Novel potent N-Methyl-d-Aspartate (NMDA) receptor antagonists or s1 receptor ligands based on properly substituted 1,4-dioxane ring 61
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 61
Synthesis and characterization of new bivalent agents as melatonin- and histamine h3-ligands. 58
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells 53
New selective PDE4D inhibitors devoid of sedative effects in mice 51
Pharmacological characterization of a new non-himidazole histamine H3 antagonist 50
Synthesis, biological activities and pharmacokinetic properties of new fluorinated derivatives of selective PDE4D inhibitors 48
Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M1 and M2 45
Su1816–Protection by Ccr6 Blockade in a Murine Model of Crohn’s Disease 40
Micro-fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in Mice 38
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 17
Human colonoid-derived monolayers and Caco-2: comparative analysis of inflammatory responses 10
Totale 5.750
Categoria #
all - tutte 21.819
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.819


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020165 0 0 0 0 0 0 0 0 0 94 28 43
2020/2021444 7 43 22 23 73 37 56 19 68 21 56 19
2021/2022391 21 16 25 48 24 17 32 32 18 27 13 118
2022/20231.393 168 170 84 106 129 154 30 63 407 14 53 15
2023/2024656 23 54 12 29 43 143 67 36 24 37 70 118
2024/20251.226 84 87 114 124 188 196 74 68 188 103 0 0
Totale 5.750